Red blood cell membrane phospholipid bilayer (none commonly used specifically for red blood cell membrane phospholipid bilayer; general abbreviations include RBC membrane or phospholipid bilayer in broad contexts, but these are not formal abbreviations for the target.)

The red blood cell membrane phospholipid bilayer is a thin, flexible barrier composed of two layers of phospholipid molecules, with hydrophilic heads facing outward and hydrophobic tails inward, forming a selectively permeable structure pivotal to red blood cell integrity and function. It provides the mechanical flexibility necessary for red blood cells to traverse capillaries, maintains homeostasis by regulating the passage of nutrients and ions, and anchors a variety of membrane proteins involved in transport, signaling, and structural support. Lipid asymmetry—especially the confinement of phosphatidylserine to the inner leaflet—is vital for cell survival and immune evasion. The bilayer itself is not a conventional therapeutic target, but its disruption or alterations in its associated structures can play roles in hemolytic anemias and susceptibility to infections such as malaria. Lipid rafts, specialized microdomains within the bilayer enriched with cholesterol and sphingolipids, serve as platforms for cell signaling and pathogen interaction. Key scientific notes: - This entry does not represent a druggable molecular target but a structural entity. - Related protein targets (e.g., band 3, spectrin, pumps/transporters) are potential drug targets, but not the bilayer lipid structure itself.

Other names

Red blood cell membrane lipid bilayerErythrocyte plasma membraneRBC membrane bilayerLipid bilayer (RBC-specific context)Phospholipid bilayer (RBC-specific context)

Not applicable for the bilayer as a direct target. Mechanisms of action for drugs modulating RBC function usually involve proteins embedded within or associated with the bilayer, not the lipid structure itself.